Global Financial Private Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$5.16M Sell
31,404
-879
-3% -$135K 0.32% 85
2020
Q1
$4.48M Sell
32,283
-3,260
-9% -$448K 0.28% 97
2019
Q4
$4.67M Sell
35,543
-142
-0.4% -$16.5K 0.23% 110
2019
Q3
$3.99M Sell
35,685
-4,635
-11% -$516K 0.2% 112
2019
Q2
$4.47M Buy
40,320
+29,625
+277% +$3.49M 0.22% 118
2019
Q1
$1.39M Buy
+10,695
New +$1.3M 0.07% 210
2018
Q4
Sell
-4,846
Closed -$520K 435
2018
Q3
$520K Sell
4,846
-1,868
-28% -$187K 0.02% 375
2018
Q2
$573K Buy
6,714
+3,135
+88% +$257K 0.02% 345
2018
Q1
$277K Sell
3,579
-645
-15% -$51.9K 0.01% 459
2017
Q4
$357K Sell
4,224
-440
-9% -$37.4K 0.01% 403
2017
Q3
$399K Buy
+4,664
New +$383K 0.01% 355

Other funds holding LLY

Global Financial Private Capital's LLY Position: Q2 2020 in Review

Global Financial Private Capital reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2020, selling an estimated $135K and leaving 31,404 shares worth $5.16M. The position accounts for 0.32% of the portfolio, ranked #85.

Global Financial Private Capital first reported a position in LLY in Q3 2017 and has held it in 11 quarters since. 1,765 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Global Financial Private Capital held 31,404 shares of Eli Lilly worth $5.16M as of Q2 2020.
  • Global Financial Private Capital sold 879 Eli Lilly shares in Q2 2020, an estimated $135K.
  • Eli Lilly made up 0.32% of Global Financial Private Capital's portfolio in Q2 2020, its #85 holding.
  • Global Financial Private Capital first reported a position in Eli Lilly in Q3 2017 and has held it in 11 quarters since.
  • 1,765 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.